Hatib, Bb Boy E.
HRN: 25-65-26 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/09/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
08/09/2024
08/16/2024
IV
16 MG
Q 24 HRS
NEONATAL SEPSIS
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes